2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman has been researched along with Fibromyalgia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atzori, L; Cacace, E; Era, B; Fais, A; Ruggiero, V | 1 |
1 other study(ies) available for 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman and Fibromyalgia
Article | Year |
---|---|
Plasma phospholipase, γ-CEHC and antioxidant capacity in fibromyalgia.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Antioxidants; Biomarkers; Case-Control Studies; Chromans; Enzyme-Linked Immunosorbent Assay; Female; Fibromyalgia; Humans; Middle Aged; Phosphatidylcholine-Sterol O-Acyltransferase; Phospholipases A2, Secretory; Propionates; Quality of Life; Severity of Illness Index; Surveys and Questionnaires | 2017 |